Partson Maradzika

Partson Maradzika serves as a key procurement lead within the W40M MRCO East under the Department of the Army, responsible for managing acquisitions that sustain and modernize military medical and laboratory capabilities. He oversees the procurement of clinical diagnostic systems, surgical instrumentation, biomedical maintenance services, and laboratory reagents critical to field and garrison medical readiness. His portfolio supports the Army’s mission to ensure rapid, accurate, and deployable healthcare delivery through advanced medical technologies, with a focus on procurement processes that align with Defense Health Agency standards and Army Medical Command priorities. Maradzika maintains consistent relationships with leading medical technology providers including Abbott Laboratories Inc. and Combat Medical Systems LLC, partnering with vendors specializing in in-vitro diagnostics, surgical tooling, and field-deployable medical equipment. His contracting patterns reflect a preference for established industry suppliers with proven compliance in FDA-regulated and military-specification medical products, while also engaging niche providers of biomedical repair and diagnostic reagent manufacturing. These partnerships are characterized by long-term performance reliability and adherence to stringent military logistics and quality assurance protocols. His procurement strategy prioritizes open competition, with 85.2% of awards issued without set-aside designations, reflecting a mission-driven emphasis on capability speed and technical adequacy. Nevertheless, he actively supports small business participation, with 14.8% of contracts awarded under total small business set-asides in accordance with FAR 19.5, demonstrating a balanced approach between operational urgency and socioeconomic obligations. Maradzika’s primary NAICS focus areas include Surgical and Medical Instrument Manufacturing, In-Vitro Diagnostic Substance Manufacturing, and Electronic and Precision Equipment Repair and Maintenance. His expertise lies in acquiring high-precision diagnostic systems, sterilizable surgical tools, and maintenance services for biomedical equipment, ensuring that Army medical units remain equipped with FDA-cleared, MIL-SPEC-compliant technologies essential for combat support and garrison healthcare operations.